Number | Cited Articles |
1 |
Ulrich Mayr, Marina Lukas, Mayada Elnegouly, Christine Vogt, Ulrike Bauer, Joerg Ulrich, Roland M. Schmid, Wolfgang Huber, Tobias Lahmer. Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. Journal of Clinical Medicine 2020; 9(9): 2865 doi: 10.3390/jcm9092865
|
2 |
Han Wang, Ning Yang, Yan Li, Fangfang Zhang, Na Xie, Peiran Li, Zhiqiang Sun, Jiangong Zhu, Yuanli Mao, Boan Li. Adjusted Intensive Care Infection Score (ICISΔ)—A new approach for prediction of ascitic fluid infection in patients with cirrhosis. Digestive and Liver Disease 2019; 51(1): 104 doi: 10.1016/j.dld.2018.06.006
|
3 |
Philipp Lutz, Hans Dieter Nischalke, Ulrich Spengler. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 977 doi: 10.1007/978-94-007-7675-3_3
|
4 |
Ioannis Koutsounas, Garyfallia Kaltsa, Spyros I Siakavellas, Giorgos Bamias. Markers of bacterial translocation in end-stage liver disease. World Journal of Hepatology 2015; 7(20): 2264-2273 doi: 10.4254/wjh.v7.i20.2264
|
5 |
Samuel Raimundo Fernandes, Patrícia Santos, Narcisa Fatela, Cilénia Baldaia, Rui Tato Marinho, Helena Proença, Fernando Ramalho, José Velosa. Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis. Journal of Clinical Laboratory Analysis 2016; 30(6): 1139 doi: 10.1002/jcla.21994
|
6 |
Toru Shizuma. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World Journal of Hepatology 2018; 10(2): 254-266 doi: 10.4254/wjh.v10.i2.254
|
7 |
Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites. Journal of Cancer Research and Clinical Oncology 2020; 146(12): 3207 doi: 10.1007/s00432-020-03363-y
|
8 |
Xianmei Wu, Junli Luo, Wenxiang Huang, Bei Jia, Tao Luo. Role of ascitic endocan levels in the diagnosis of spontaneous bacterial peritonitis in decompensated cirrhosis. Biomarkers 2020; 25(4): 360 doi: 10.1080/1354750X.2020.1764107
|
9 |
Philipp Lutz, Kenneth Pfarr, Hans Dieter Nischalke, Benjamin Krämer, Felix Goeser, Andreas Glässner, Franziska Wolter, Pavlos Kokordelis, Jacob Nattermann, Tilman Sauerbruch, Achim Hoerauf, Christian P. Strassburg, Ulrich Spengler. The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. Clinical Chemistry and Laboratory Medicine (CCLM) 2015; 53(12) doi: 10.1515/cclm-2015-0284
|
10 |
Danai Agiasotelli, Alexandra Alexopoulou, Larisa Vasilieva, Emilia Hadziyannis, Dimitris Goukos, George L. Daikos, Spyros P. Dourakis. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver International 2017; 37(4): 576 doi: 10.1111/liv.13264
|
11 |
Mahmoud Dibas, Ahmad Mamoun Rajab, Mohamed Saddik Zaghloul, Mohammad J. Atiah, Saadi Aljundi, Ahmed Amir, Nazmus Saquib. Ascitic calprotectin for the diagnosis of spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 2020; doi: 10.1097/MEG.0000000000001709
|
12 |
Philipp Lutz, Hans Dieter Nischalke, Christian P Strassburg, Ulrich Spengler. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World Journal of Hepatology 2015; 7(3): 304-314 doi: 10.4254/wjh.v7.i3.304
|
13 |
Annika Gauss, Peter Sauer, Adolf Stiehl, Christian Rupp, Johannes Krisam, Yvonne Leopold, Petra Kloeters-Plachky, Wolfgang Stremmel, Daniel Gotthardt. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis. Medicine 2016; 95(17): e3510 doi: 10.1097/MD.0000000000003510
|
14 |
Yasmin Nabiel, Ghada Barakat, Sally Abed. Serum CD64 and ascitic fluid calprotectin and microRNA-155 as potential biomarkers of spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 2019; 31(8): 1064 doi: 10.1097/MEG.0000000000001443
|
15 |
Ahmed Abdel-Razik, Mostafa Abdelsalam, Doaa F. Gad, Ahmed Abdelwahab, Mona Tawfik, Rasha Elzehery, Rania Elhelaly, Ahmad S. Hasan, Niveen El-Wakeel, Waleed Eldars. Recurrence of spontaneous bacterial peritonitis in cirrhosis. European Journal of Gastroenterology & Hepatology 2020; 32(6): 718 doi: 10.1097/MEG.0000000000001578
|
16 |
Eman M Abdel Rahman, Fatma A Attia, Ayman Alsebaey, Mohammad Abdel Khalik Elkady, Maha Mohammed Sayed, Alaa Reda Awad, Eman Ahmed El-Seidi. Ascitic calprotectin as a useful marker in the diagnosis of spontaneous bacterial peritonitis in adults. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-0022-7
|
17 |
Ahmed Abdel-Razik, Nasser Mousa, Dina Elhammady, Rania Elhelaly, Rasha Elzehery, Sherif Elbaz, Mohamed Eissa, Niveen El-Wakeel, Waleed Eldars. Ascitic Fluid Calprotectin and Serum Procalcitonin as Accurate Diagnostic Markers for Spontaneous Bacterial Peritonitis. Gut and Liver 2016; 10(4): 624 doi: 10.5009/gnl15120
|
18 |
Delphine Weil, Alexandra Heurgue-Berlot, Elisabeth Monnet, Sophie Chassagne, Jean-Paul Cervoni, Thomas Feron, Céline Grandvallet, Emilie Muel, Jean-Pierre Bronowicki, Gérard Thiefin, Vincent Di Martino, Karine Bardonnet, Thierry Thévenot. Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis. Hepatology Research 2019; 49(1): 72 doi: 10.1111/hepr.13239
|
19 |
Maryam Nasereslami, Zhila Khamnian, Yaghoub Moaddab, Zahra Jalali. Diagnostic and prognostic role of ascitic fluid calprotectin level: six-month outcome findings in cirrhotic patients. Scandinavian Journal of Gastroenterology 2020; 55(9): 1093 doi: 10.1080/00365521.2020.1794023
|
20 |
Irina B. Baranovskaya, Ol’ga F. Samokhina, Galina A. Demidchenko, Irina P. Sysoeva. ESTIMATION OF METASTATIC NEOGENESIS IN ASCITIC EXUDATE BY AN AUTOMATED ANALYSIS OF BIOLOGICAL LIQUIDS. Kuban Scientific Medical Bulletin 2019; 26(1): 58 doi: 10.25207/1608-6228-2019-26-1-58-66
|
21 |
Philipp Lutz, Hans Dieter Nischalke, Ulrich Spengler. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_3-1
|